Deep Blue

Not a registered adviser. Posts are commentary, not investment advice.

[Deep Blue @deepblueequity]

$CYCL A clean, debt‑free public vehicle now positioned for a transformative AI‑Robotics acquisition. No dilution. No toxic debt. No legacy baggage. A rare OTC structure built for scale — and a pending merger that could redefine its footprint.
https://t.co/jYT1BPlAHA

[Deep Blue @deepblueequity]

$OTLK Holding through the run up to July 29 FDA date...
could see $5.00 by then in my opinion...I believe the market has concluded FDA approval is imminent... analyst upgraded price target to $10 on BLA submission today.

[Deep Blue @deepblueequity]

$OTLK
Ascendiant Capital — Buy, price target raised from $6 → $10
confirms the FDA accepted the resubmitted BLA and set a PDUFA target action date of July 29 2026, which underpins Ascendiant’s upgrade

[Deep Blue @deepblueequity]

$SRXH- If SEC rules on merger this week and filings start to drop this might explode on Eric Jackson taking over as CEO and Chairman.

[Deep Blue @deepblueequity]

$OTLK BLA submitted
FDA approval is the inflection point. OTLK becomes the first on‑label ophthalmic bevacizumab in the U.S.

— unlocking a $600M–$1.2B valuation window.

De‑risked. First‑to‑market. Strong economics.

[Deep Blue @deepblueequity]

$SRXH
Upon the closing of the merger, Jackson is slated to step in as Chief Executive Officer and Chairman of the combined company

SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson

https://t.co/khfBkK1lGY

[Deep Blue @deepblueequity]

$OTLK- BLA submitted- 1-60 days for FDA to rule
There is a very good chance of approval here

[Deep Blue @deepblueequity]

@moonmarket What do you think Moon- interested in an OTC play- just like back in the day
https://t.co/9chSMNVB7l

[Deep Blue @deepblueequity]

$CYCL A clean, debt‑free public vehicle now positioned for a transformative AI‑Robotics acquisition. No dilution. No toxic debt. No legacy baggage. A rare OTC structure built for scale — and a pending merger that could redefine its footprint.
https://t.co/jYT1BPlAHA

[Deep Blue @deepblueequity]

@moonmarket @HeartRateTrader You nailed it Moon... thank you

[Deep Blue @deepblueequity]

$CYCL CEO released acquisition PR on the weekend for California AI Robotics company...then posted this following day.
Seems he is in San Fran to close the deal perhaps.
There is a company that fits the description he laid out in PR...that company is Agtonomy

[Deep Blue @deepblueequity]

@moonmarket Great call Moon.... here is an OTC play if your interested..check it out https://t.co/CnA2jvULNo

[Deep Blue @deepblueequity]

$CYCL CEO Nugent has arrived in San Francisco presumably to procure an AI Robotics acquisition with global reach.
PR released June 13
https://t.co/qhVC45wYP2
https://t.co/gxoRjNlnIQ

[Deep Blue @deepblueequity]

@FALCON_X911 I believe I know who the merger target is... cant say right now.,. but if this merger is what I think it is..its major

[Deep Blue @deepblueequity]

$CYCL CEO Nugent has arrived in San Francisco presumably to procure an AI Robotics acquisition with global reach.
PR released June 13
https://t.co/qhVC45wYP2
https://t.co/gxoRjNlnIQ

[Deep Blue @deepblueequity]

$SRXH Eric Jackson is slated to become CEO and Chairman of the merged SRx Health and his crypto company EMJX
Deadline for target milestones is June 15

@ericjackson

[Deep Blue @deepblueequity]

$SRXH
EMJ Crypto Technologies entered into a definitive agreement to acquire SRx Health Solutions Inc. in a reverse merger Eric Jackson is set to head a crypto treasury firm following a reverse merger with SRx SRXH canceling 125M shares of common stock in balance sheet cleanup

[Deep Blue @deepblueequity]

$SRXH The merger between SRx Health Solutions (NYSE American: SRXH) and Eric Jackson's EMJ Crypto Technologies (EMJX) is expected to officially close on June 15, 2026. [1]

[Deep Blue @deepblueequity]

@MichealNugent22 Good Luck- when can we expect the good news of LOI or perhaps something bigger ?

[Deep Blue @deepblueequity]

OTC Merger
Company has no toxic debt or warrants outstanding, no ATM, no shelf or equity line..no dilution in years.
94% owned by CEO
Low float
https://t.co/Z0tk9qR3vs

[Deep Blue @deepblueequity]

Potential for a big merger developing in the OTC markets- stay tuned

[Deep Blue @deepblueequity]

Potential for a big merger developing in the OTC markets- stay tuned

[Deep Blue @deepblueequity]

Shotwell says a $TSLA tie‑up “might make Elon’s life a little easier”
$SPCX has already absorbed xAI
Joint platforms
Tesla already holds SpaceX equity via the xAI deal
Dan Ives (Wedbush) is calling 80–90% odds of a 2027 Tesla–SpaceX deal
Oppenheimer-a merger remains “plausible.”